Denali Therapeutics Inc. (DNLI) › Shares OutstandingDenali Therapeutics Inc. (DNLI) — Shares OutstandingAnnual figures by period end, from SEC filings.2017-12-31: 87.48M2018-12-31: 94.66M2019-12-31: 96.19M2020-12-31: 120.53M2021-12-31: 122.28M2022-12-31: 135.97M2023-12-31: 138.39M2024-12-31: 144.22M2025-12-31: 156.18M156.18M2017-12-31Shares Outstanding (shares)2025-12-31Period endedShares OutstandingChange YoYSource filing2025-12-31156.18M+8.3%2026-02-26Balance as of period end2024-12-31144.22M+4.2%2026-02-26Balance as of period end2023-12-31138.39M+1.8%2025-02-27Balance as of period end2022-12-31135.97M+11.2%2024-02-28Balance as of period end2021-12-31122.28M+1.5%2023-02-27Balance as of period end2020-12-31120.53M+25.3%2022-02-28Balance as of period end2019-12-3196.19M+1.6%2021-02-26Balance as of period end2018-12-3194.66M+8.2%2020-02-27Balance as of period end2017-12-3187.48M—2019-03-12Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per ShareWeighted Average Diluted SharesEPS (Basic)